Company Name: |
DC Chemicals
|
Tel: |
021-58447131 13564518121 |
Email: |
sales@dcchemicals.com |
Products Intro: |
Product Name:ASP2453 CAS:2241719-73-1 Purity:98% HPLC Package:100mg,250mg,1g
|
2-Propen-1-one, 1-[7-[6-cyclopropyl-2-[[1-(3-methoxypropyl)-4-piperidinyl]oxy]-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)-4-quinazolinyl]-2,7-diazaspiro[3.5]non-2-yl]- manufacturers
- ASP2453
-
- $118.00 / 1mg
-
2024-11-19
- CAS:2241719-73-1
- Min. Order:
- Purity: 96.57%
- Supply Ability: 10g
|
| 2-Propen-1-one, 1-[7-[6-cyclopropyl-2-[[1-(3-methoxypropyl)-4-piperidinyl]oxy]-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)-4-quinazolinyl]-2,7-diazaspiro[3.5]non-2-yl]- Basic information |
Product Name: | 2-Propen-1-one, 1-[7-[6-cyclopropyl-2-[[1-(3-methoxypropyl)-4-piperidinyl]oxy]-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)-4-quinazolinyl]-2,7-diazaspiro[3.5]non-2-yl]- | Synonyms: | 2-Propen-1-one, 1-[7-[6-cyclopropyl-2-[[1-(3-methoxypropyl)-4-piperidinyl]oxy]-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)-4-quinazolinyl]-2,7-diazaspiro[3.5]non-2-yl]-;ASP2453;Ras,inhibit,ASP2453,Inhibitor,ASP 2453,ASP-2453 | CAS: | 2241719-73-1 | MF: | C40H48F3N7O4 | MW: | 747.85 | EINECS: | | Product Categories: | | Mol File: | 2241719-73-1.mol | |
| 2-Propen-1-one, 1-[7-[6-cyclopropyl-2-[[1-(3-methoxypropyl)-4-piperidinyl]oxy]-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)-4-quinazolinyl]-2,7-diazaspiro[3.5]non-2-yl]- Chemical Properties |
Boiling point | 855.8±75.0 °C(Predicted) | density | 1.36±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | form | Solid | pka | 12.36±0.40(Predicted) | color | White to yellow |
| 2-Propen-1-one, 1-[7-[6-cyclopropyl-2-[[1-(3-methoxypropyl)-4-piperidinyl]oxy]-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)-4-quinazolinyl]-2,7-diazaspiro[3.5]non-2-yl]- Usage And Synthesis |
Biological Activity | ASP2453 is a potent, selective and covalent KRAS G12C inhibitor. ASP2453 inhibits the Son of Sevenless (SOS)-mediated interaction between KRAS G12C and Raf with an IC50 value of 40 nM. | References | [1]. Nakayama A, et al. Characterisation of a novel KRAS G12C inhibitor ASP2453 that shows potent anti-tumour activity in KRAS G12C-mutated preclinical models. Br J Cancer. 2021 Nov 18. |
| 2-Propen-1-one, 1-[7-[6-cyclopropyl-2-[[1-(3-methoxypropyl)-4-piperidinyl]oxy]-7-(5-methyl-1H-indazol-4-yl)-8-(2,2,2-trifluoroethoxy)-4-quinazolinyl]-2,7-diazaspiro[3.5]non-2-yl]- Preparation Products And Raw materials |
|